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Extensive multigene deletions have been described in the human immunoglobulin heavy-chain constant re- 
gion genes, some of them encompassing perhaps more than 100 kilobases. These deletions have all been 
observed in healthy individuals although these individuals lacked several immunoglobulin class or subclas- 
ses, being either homozygous for one deletion or heterozygous for two different deletions. The high frequen- 
cy of consanguinity in the Tunisian population accounts for the high frequency of individuals displaying 
one or the orther of these deletions in a homozygous tate. 
Multigene deletion; Immunoglobulin; CH gene; Immunoglobulin deficiency; (Human) 
1. INTRODUCTION 
In the human immunoglobulin system, there are 
given classes (IgM, IgD, IgG, IgE and IgA) which 
are defined by the isotypic antigenic determinants’, 
physico-chemical and biological activities of their 
heavy chains 01, 6, y, 6 and a respectively). Fur- 
thermore, subclasses are known for IgG (IgGl, 
IgG2, IgG3 and IgG4) and IgA (IgAl and IgA2) 
[l]. The constant region of the yr, ~2, 73, CYZ and 
6 heavy chains can also be identified by allotypic 
antigenic determinants located on one or the other 
of the heavy chain constant (CH) domains [2,3]. 
These antigens provide genetic markers for IgGl, 
IgG2, IgG3, IgA2 and IgE and are, consequently, 
called Glm, G2m, G3m, A2m and Em allotypes, 
respectively. These allotypes are useful tools in the 
characterization of populations [4,5] and genetics 
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of immunoglobulins [6-91. The inheritance of 
unexpected and unusual sets of allotypes is par- 
ticularly interesting since they reveal genetic events 
(point mutations, duplications, deletions, ex- 
changes of CH exons, gene conversion, hybrid 
genes . ..) which have occurred at the level of the 
coding sequences [6-91. 
Due to the availability of specific CH gene 
probes, these genetic events affecting the locus of 
the human immunoglobulins which has been map- 
ped on chromosome 14 [lo] at band q32 [Ill are 
now also studied at the DNA level. Here, we 
review the multigene deletions which have recently 
been observed in the immunoglobulin heavy-chain 
constant region genes of healthy individuals. 
2. DETECTION OF THE HUMAN CH GENES 
WITH SPECIFIC PROBES 
2.1. C/ and C6 genes 
Human DNA samples digested with BamHI en- 
zyme and hybridized with a Cp-specific probe 1121 
show a unique 17 kb hybridizing BamHI fragment 
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1131 whereas hybridization with a C&specific 
probe detects an 11 kb hybri~zing BamHI frag- 
ment [13j. 
2.2. Cy genes 
Cy probes containing the coding sequences of 
the constant regions of the y3 or y4 genes [14] 
detect all the Cy genes due to the high degree of 
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Fig. 1. Filter hybridization of genomic DNA of the TOU 
family with a y constant region probe [22]. Genomic 
DNA was digested with BarnHI and fractionated on 
0.8% agarose, The filter was hybridized with a Cy probe 
[14] which detects all CT subclass genes. The lines on the 
left of the panel signify the location of restriction 
fragments found in a control DNA (lane I$). N, control 
DNA; A, individuaIs homozygous for the deletion I (see 
test and fig.4); B, ind~vidu~5 carrying deletion I on one 
chromasome 14 and deletion II on the other 
chromosome 14 (see fig.4). 
homoiogy between the human Cy genes [15]. 
Moreover, restriction fragment length polymor- 
phism has been observed for the y genes and the 
Cy probes detect between five and eight hybridiz- 
ing BamHI fragments [I31 (fig.1, iane N). 
2.3. Cc genes 
Human DNAs analyzed using a C&specific 
probe [I61 show the presence of three BumHI frag- 
ments (2.7, 6 and 9 kb) [16-181 (fig.2, lanes N). It 
has been demonstrated that the 2.7 kb fragment 
carries the active CE gene f 16- 1 S] whereas the 6 and 
9 kb fragments represent pseudogenes called $61 
and @2, respectiveiy [17-191. The pseudogene $61 
is located within the CH-gene cluster between Cyl 
and Crvr [19] on chromosome 14 whereas &Z is a 
processed-type pseudogene localized on chromo- 
some 9 [20]. 
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Fig.2. Filter hybridization of genomic DNA of the TOU 
family I221 using an E constant region probe 1161. 
Genomic DNA was digested with BarnHI and frac- 
tionated on 0.8% agarose. N, A and B as in fig. 1, 
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Fig.3. Southern filter hybridization of genomic DNA of 
the TOU family with an LY constant region probe f22]. 
Genomic DNA was digested with PstI and fractionated 
on 1.4% agarose. The filter was hybridised with a ti 
probe ((Y 2XP8 [19]). N, A and B as in fig.1 
2.4. Gz genes 
The restriction enzyme PstI yields two fragments 
containing cyt (1.2 kb) and cu2 (2 kb) genes [13,191 
(fig.3, lanes N) when probed with the clone 
a2 x P8 (which encompasses most of the CH2 ex- 
on, the beginning of the CH3 exon plus the in- 
tervening sequence between them) [19]. The 
advantage of this subclone is that it does not 
overlap the Pst site and therefore gives only one 
fragment per gene. Moreover, the same probe can 
be used for the determination of the A2m allotypes 
by restriction fragment length polymorphism [21]. 
3. A LARGE DELETION INCLUDING THE 
II ($1, Cy2, Cy4, $r, rte AND Gw GENES 
A N B A A The simultaneous absence of the IgGl, IgG2, 
Probands 
Table 1 
Serological markers of haplotypes 
G3m Glm (~1 G2m A2m Type of deletion References 
TAK3 (family HASS*) 
TOU 11-l 
TOU II-4 (EZZ) 
TOU II-5 
TOU I-2 
TOU II-3 
SAF I-2 
FRO I-2 
T 17 
b 
b 
c b g 
b 
- - 2 
za - . . 2 
f - - 1 
b f - - 1 
g za - - 1 
b za - - 2 
- - 2 
2 
I/I 13 
I/I 13.23 
23 
III/III 25 
25 
IV/IV 26 
* TAK3’s two grandsons display the same type of deletion (M.P.L. and G.L., unpublished) 
Ahotypic markers of yr (Glm) and ys (G3m) heavy chains are indicated in Arabic nomenclature. 
The absence of Glm allotypes due to the absence of the IgGl subclass is indicated by a dash (-). 
Only one allotype is defined on the ~2 chain and may or may not be present; two dots indicate the 
absence of this alfotype. Nonetheless, the IgG2 subclass is present. The absence of the ~2 allotypic 
marker (G2m) due to the absence of IgG2 is indicated by a dash (-). Two allotypes have been 
described for the 72 chain, A2m(l) and A2m(2). No allotype being known for the LYI chain, the - 
signs indicate the absence of isotypic markers for the IgAl subclass. b = b0, bl, b3, b4, b5, u, v; 
g = gl, g5, u, v 
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Table 2 
Different types of IgCH multigene deletions in healthy individuals 
Origin Number of Absent Type of deletion References 
cases immunoglobulins (see fig.4) 
Family HASS, 
Tunisia 3 IgGl,IgG2,IgG4,IgAl I/I 13 
Family TOU, 
Tunisia 3 IgGl ,IgG2,IgG4,IgAl I/I 13,23Aa 
2 IgAl I/II 23Ba 
Southern Italy 1 IgG2,IgG4,igAl,IgE III/III 25 
Sardinia 1 IgG2,IgG4,IgAl III/IV 25 
Tunisia 1 IgG2,IgG4,IgAl IV/IV 26 
a A and B correspond to the hybrizations in Figs l-3 
The genes implicated in the different types of deletion, as indicated in fig.4, are the following: dele- 
tion I: Cyr, &r, Car, l,k, CYZ, Cy4; deletion II: &I, GXI, +y; deletion III: CCYI, &r, CW, Cy4, Cc 
deletion IV: +CI, CCYU~, $r, CYZ, ($4 
IgG4 and IgAl immunoglobulins has been unam- 
biguously demonstrated in a healthy 75year-old 
Tunisian woman (designated TAK3, family HASS) 
by testing for allotypes, isoallotypes and for 
isotypes of these four subclasses [22] (table 1). On- 
ly IgM, IgD, IgG3, IgE and IgA2 were present. 
The patterns of hybridization of peripheral blood 
leucocyte DNA with Cp, c6, Cy, Ce: and Ccu 
probes, using Southern blot analysis, revealed the 
absence of the Cyi, Cyz, Cyd and Ccvi genes as well 
as the absence of the Y+ and &r genes [13]. An 
identical deletion was found in three individuals 
belonging to a second Tunisian family (family 
TOU) 1231, and more recently in two TAK3’s 
grandsons (M.P.L. and G.L., unpublished) (tables 
1 and 2). For these 6 individuals the hybridization 
pattern with a Cy probe showed a unique 10.2 kb 
BamHI band representing the Cy3 gene and, conse- 
A B 2 
/ \ , 1 
P d Y3 71 lCt1 al 1Lr Y2 Y4 e a2 
S’a l I m B 1 -A__. fi a n , 3’ __ 
8 26 19 13 18 23 10 Lb 
Fig.4. Multigene deletions in the human immunoglobulin heavy-constant region genes. These deletions have all been 
described in healthy individuals, either homozygous for these deletions or heterozygous for two different deletions (see 
table 1). Deletions I 113,231, II 1231, III ]25], and IV 125,261 are described in the text. We need to await gene cloning 
to establish the precise length and junction points of these different deletions. 
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quently, the absence of the Cyr, Cyz, Cy4 and $7 
genes 113,231 (fig.1, lanes A). The Ce probe show- 
ed the 2.7 kb and 9 kb BurnHI fragments represen- 
ting, respectively, the Ce and &2 genes, the $61 
being deleted [13,23] (fig.2 lanes A), whereas 
hybridization with the &-specific probe revealed a 
unique 2 kb Pst fragment representing the C& 
gene, the Ccvi gene (1.2 kb Pst fragment) being 
deleted (fig.3, lanes A). 
4. ORDER OF THE Ig CH GENES IN HUMAN 
When these deletions including yl, ~2, y4, $61 
and LYI were first described fl3] (deletion I, fig.4), 
two groups of cosmid clones had just been iden- 
tified, which seemed to encompass y3- yi- +&et- tyi 
(region A) and y2- y4- e- CYZ (region B) [19] (fig.4). 
The patterns of the deletions enabled us to predict 
an order for the groups of cosmid clones with 
region A in 5’ of region B, as the deletions start 
downstream of y3 (region A) and end upstream of 
the active 6 gene (region B) [13,19]. 
Moreover, the absence of the +y gene in our 
samples howed that the cl_r gene was also included 
in the deletion and therefore must be located be- 
tween the cyr and y2 genes on chromosome 14 [23]. 
Human Cp and c6 genes have been shown to be 8 
kb apart 1241. The order of the human CH genes 
is, therefore, the following [13,19,23,24]: 
5’“p .e!L 6 _,.._ ye 26kb 19 kb 13 kb 71 ~- #fl ___ 
18 kb 
a1 -...- $y...- yz ~ 
23 kb 10 kb 
y4 - E ~ m-3' 
5. A SHORTER DELETION ENCOMPASSING 
Heterozygous individuals for the previous dele- 
tions shoufd give a normal pattern of hybridization 
using CH-specific probes due to the presence of a 
normal chromosome 14. Unexpectedly, DNA from 
two heterozygous members of the TOU family 
showed cy and 6 hybridization patterns identical to 
those of the homozygotes, e.g. characterized by 
the absence of the &I and Crrl genes (figs 2,3, 
lanes B), whereas the Cy hybridization showed a 
four-band pattern due to the absence of the +y 
gene [23] (fig. 1, lanes B). These results raised the 
extremely intriguing possibility that two different 
types of chromosomal aberration existed in the 
TOU family, one carrying a small deletion in- 
cluding the LYE gene as well as the &i and #y genes 
(deletion II, fig.4), and the other carrying the 
previously described deletion which encompasses 
yt, ~2, ~4, gy, &I and LYI genes (deletion I, fig.4). 
6. OTHER CH MULTIGENE DELETIONS 
More recently two other multiple gene deletions 
have been described in the heavy-chain cluster, 
both of them in healthy individuals. The first one, 
found in the homozygous state in a southern 
Italian, encompasses ~1, l6y, 72, y4 and E genes 
1251. This deletion (deletion III, fig.4) is different 
from the deletion I in that it does not include the 
Cyi gene but the ct- sequence, and therefore, the 
absence of IgE is observed (table 2). 
A Sardinian was heterozygous for this deletion 
and for a fourth type of deletion involving &I, QTI, 
$y, yz and y4 genes [25] (deletion IV, fig.4). A 
similar deletion has recently been described in the 
homozygous state in a Tunisian but associated 
with a different haplotype [26] (table 1). 
7. IMMUNOLOGICAL IMPLICATIONS 
Deletion I [13,23] shows that a human being can 
survive without four immuno~obulin subclasses 
even including IgGl and IgAl, quantitatively the 
most important IgG and IgA subclasses in normal 
sera (table 2). Moreover, both the women TAK3 
and TOU 11-l (table 1) have had five pregnancies 
that were completed to five live births [22,23]. 
The high level of IgG3 [22], which is the IgG 
subclass most easily transported across the placen- 
ta, has permitted the fetus and the newborns to 
survive until their own immunoglobulin produc- 
tion had started. Probably the IgA2 levels in the 
colostrum and maternal milk were also higher than 
the normal values and may have permitted suffi- 
cient immunological protection in the 
gastrointestinal tracts of their nursing infants, In 
the homozygous state for deletion III [25], the 
absence of IgE has apparently no deleterious 
effects. 
None of the abnormal patterns of im- 
munoglobulins mentioned here have clinical conse- 
quences and all probands appear healthy. This 
could be due to the unrestricted use of the available 
VH gene repertoire by the remaining Cy and CLY 
235 
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subclasses. Anti-carbohydrate antibodies are 
almost exclusively confined to the IgG2 subclass in 
adults. In individuals with immuno~lob~i~ heavy- 
chain constant region gene deletions encompassing 
the yz gene, antibodies against polysaccharide an- 
tigens were however present and, as expected, 
restricted to the remaining subclass (IgGl and/or 
IgC3) [27]. These results contrast with those found 
in IgG2-deficient individuals with a retained yz 
gene where antibodies against most polysaccharide 
antigens are absent [27,28]. 
8. SELECTIVE IMM~NUGLG~U~IN 
SUBCLASS ~EFI~I~N~IES 
The heterozygous individuals of the TQU family 
(deletions I/II), were shown to be selectively defi- 
cient in IgAl (table 2). It is noteworthy that this 
selective IgAl deficiency is a consequence of 
multigene deletions on both chromosomes and 
contrasts with IgA deficiencies where both IgAl 
and IgA2 subclasses are lacking. In these latter 
cases, we observed no & gene deletions (M.P.L. 
and Rabbit&, TX., unpublished), Similarly, the 
CXZ gene was also present in a selective IgA2 defi- 
ciency 1291. Recently, using a specific Gcy3 probe 
[30], we showed that a selective IgG3 deficiency 
[6,3 11 was not due to a Cy3 gene deletian [30f. Fur- 
ther studies, including cloning and sequencing, 
should be carried out in order to eiucidate the 
mechanism of these seIective immunoglobulin 
subclass deficiencies, which are not due to gene 
deletion. 
9. UNEQUAL CROSSING-OVER OR 
LOOPING-OUT MODELS 
The frequency of the IgCH muIti~e~e deletions 
can be estimated to be about 0.01. Since these dele- 
tions are harmless, they are not detected when pre- 
sent in a single dose, but are unmasked in 
homozygous individuals. In populations where 
consanguinity occurs as a rule, there is a greater 
chance af finding homozygosity for uncommon 
chromosomes. 
It is very possible that many different types of 
gene deletions can occur without deleterious ef- 
fects and that the human CH locus, which seems to 
possess a remarkable evolutionary flexibility, may 
be undergoing continual expansion and contrac- 
236 
tion 1321. It is conceivable that CH gene deletions 
could be mediated either by unequal crossing-over 
between sister chromatids or by internal looping- 
out models. 
At present, further speculation on the 
mechanism needs to await gene cloning and ex- 
amination of the junction points of these de&ions. 
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